{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:13:47Z","timestamp":1788401627028,"version":"build-2803163510"},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","award":["2324\u2010HQ\u2010000038"],"award-info":[{"award-number":["2324\u2010HQ\u2010000038"]}],"id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Influenza Resp Viruses"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The Canadian Sentinel Practitioner Surveillance Network used the test\u2010negative design to assess KP.2 vaccine effectiveness (VE) against medically attended outpatient COVID\u201019 between November 2024 and April 2025 among participants \u2265\u200912\u2009years. Analyses included 5410 controls (19% vaccinated) and 435 COVID\u201019 cases (10% vaccinated). Nearly three\u2010quarters (72%) of contributing case viruses were genetically characterized, with XEC (35%) and KP.3.1.1 (38%) variants most commonly identified. Vaccination reduced COVID\u201019 risk by approximately half (54%; 95% CI: 36\u201368) relative to unvaccinated individuals. VE was greatest during the first 2\u2009months postvaccination, reducing risk by two\u2010thirds and declining to minimal protection by the fifth month postvaccination.<\/jats:p>","DOI":"10.1111\/irv.70222","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T17:28:56Z","timestamp":1772990936000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness of 2024\/25 KP.2 Vaccine Against Outpatient COVID\u201019 in Canada"],"prefix":"10.1111","volume":"20","author":[{"given":"Lea","family":"Separovic","sequence":"first","affiliation":[{"name":"British Columbia Centre for Disease Control  Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Sabaiduc","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control  Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Zhan","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control  Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha\u00a0E.","family":"Kaweski","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control  Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Carazo","sequence":"additional","affiliation":[{"name":"Institut National de Sant\u00e9 Publique du Qu\u00e9bec  Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romy","family":"Olsha","sequence":"additional","affiliation":[{"name":"Public Health Ontario  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard\u00a0G.","family":"Mather","sequence":"additional","affiliation":[{"name":"Public Health Ontario  Toronto Canada"},{"name":"Queen's University  Kingston Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lacroix","sequence":"additional","affiliation":[{"name":"Institut National de Sant\u00e9 Publique du Qu\u00e9bec  Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maan","family":"Hasso","sequence":"additional","affiliation":[{"name":"Public Health Ontario  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e8s","family":"Levade","sequence":"additional","affiliation":[{"name":"Institut National de Sant\u00e9 Publique du Qu\u00e9bec  Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Meunier","sequence":"additional","affiliation":[{"name":"Institut National de Sant\u00e9 Publique du Qu\u00e9bec  Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agatha\u00a0N.","family":"Jassem","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control  Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Dover","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control  Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimin","family":"Gao","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada  Winnipeg Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Bastien","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada  Winnipeg Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta\u00a0M.","family":"Skowronski","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control  Vancouver Canada"},{"name":"University of British Columbia  Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"e_1_2_13_2_1","unstructured":"Pan American Health Organization.SARS CoV2 Situation \u2010 Region of the Americas [Internet] https:\/\/www.paho.org\/en\/covid\u201019\u2010weekly\u2010updates\u2010region\u2010americas."},{"key":"e_1_2_13_3_1","unstructured":"European Medicines Agency.COVID\u201019 Medicines [Internet] https:\/\/www.ema.europa.eu\/en\/human\u2010regulatory\u2010overview\/public\u2010health\u2010threats\/coronavirus\u2010disease\u2010covid\u201019\/covid\u201019\u2010medicines."},{"key":"e_1_2_13_4_1","unstructured":"United States Food and Drug Administration.FDA Authorizes Updated Novavax COVID\u201019 Vaccine to Better Protect Against Currently Circulating Variants [Internet]. (2024) https:\/\/www.fda.gov\/news\u2010events\/press\u2010announcements\/fda\u2010authorizes\u2010updated\u2010novavax\u2010covid\u201019\u2010vaccine\u2010better\u2010protect\u2010against\u2010currently\u2010circulating."},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.7.2400076"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac234"},{"key":"e_1_2_13_7_1","unstructured":"National Advisory Committee on Immunization (NACI).National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2024\u20132025 [Internet].Public Health Agency of Canada;2024May https:\/\/www.canada.ca\/content\/dam\/phac\u2010aspc\/documents\/services\/publications\/vaccines\u2010immunization\/national\u2010advisory\u2010committee\u2010immunization\u2010statement\u2010seasonal\u2010influenza\u2010vaccine\u20102024\u20102025\/naci\u2010statement\u20102024\u201007\u201025.pdf."},{"key":"e_1_2_13_8_1","unstructured":"Public Health Agency of Canada.COVID\u201019 Vaccination: Vaccination Coverage [Internet].2024Jul https:\/\/health\u2010infobase.canada.ca\/covid\u201019\/vaccination\u2010coverage\/#a3."},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2012.031"},{"key":"e_1_2_13_10_1","unstructured":"United States Centers for Disease Control.Preliminary Estimates of COVID\u201019 Burden for 2024\u20132025 [Internet] https:\/\/www.cdc.gov\/covid\/php\/surveillance\/burden\u2010estimates.html."},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127567"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00464-25"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00242-25"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127129"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-025-01185-4"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.126961"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00058-1"},{"key":"e_1_2_13_18_1","unstructured":"K. C.Ma A.Webber A. S.Lauring et\u00a0al. Effectiveness of 2024\u20132025 COVID\u201019 Vaccination Against COVID\u201019 Hospitalization and Severe In\u2010Hospital Outcomes\u2014IVY Network 26 Hospitals September 1 2024\u2013April 30 2025 [Internet].2025 http:\/\/medrxiv.org\/content\/early\/2025\/09\/03\/2025.08.29.25334612.abstract."},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00380-9"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7406a1"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127870"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac290"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59344-7"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.70120"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae658"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2018.100003"}],"container-title":["Influenza and Other Respiratory Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.70222","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/irv.70222","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.70222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:20:40Z","timestamp":1774516840000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/irv.70222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1111\/irv.70222"],"URL":"https:\/\/doi.org\/10.1111\/irv.70222","archive":["Portico"],"relation":{},"ISSN":["1750-2640","1750-2659"],"issn-type":[{"value":"1750-2640","type":"print"},{"value":"1750-2659","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"2025-10-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70222"}}